News & Views
Lab researchers study breast cancer prevention agent
Mar 24 2010
Scott & White Healthcare researchers are hoping clinical trials will help to discover whether metastasised tumours can be managed through the treatment.
According to the organisation, patients who have the disease and are not benefiting from existing medical assistance may be eligible for Phase II of the experiments.
Dr Christopher Ruud, director of the institution's breast cancer division, said the "ultimate goal" is to offer individuals a way of coping with the condition on a day-to-day basis.
He stated: "That is one of our strategies at Scott & White to find ways to treat breast cancer that has failed other treatments."
A recent study by Danish experts questioned whether breast screening has had a positive effect on the number of deaths relating to breast cancer.
Karsten Jorgensen and Peter Gotzsche from the Nordic Cochrane Centre in Copenhagen suggested tests of this kind had a minimal impact on reducing mortality rates.
Digital Edition
ILM 49.5 July
July 2024
Chromatography Articles - Understanding PFAS: Analysis and Implications Mass Spectrometry & Spectroscopy Articles - MS detection of Alzheimer’s blood-based biomarkers LIMS - Essent...
View all digital editions
Events
Jul 28 2024 San Diego, CA USA
Jul 30 2024 Jakarta, Indonesia
Jul 31 2024 Chengdu, China
ACS National Meeting - Fall 2024
Aug 18 2024 Denver, CO, USA
Aug 25 2024 Copenhagen, Denmark